Pyxis Diagnostics
Developing novel diagnostics to predict patient response to immunotherapy.
About
Pyxis Diagnostics is focused on revolutionizing cancer treatment by developing advanced diagnostic tools. Their technology aims to predict which patients will respond to immunotherapy drugs, addressing a critical unmet need in oncology where many patients do not benefit from these life-saving treatments. Teams look it up for Healthcare, Immunotherapy, Oncology.
Frequently asked
What does Pyxis Diagnostics do?
Pyxis Diagnostics is a Healthcare company that offers Software. Teams look it up for Immunotherapy, Oncology, Next Generation Sequencing. It is based in San Diego, United States and was founded in 2017. It was formerly known as Neuromagen Pharma. Public records show about 3 people and $10M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Pyxis Diagnostics raised?
Pyxis Diagnostics has raised a total of $10M in funding. The most recent round on record is Seed.
Where is Pyxis Diagnostics headquartered?
Pyxis Diagnostics is headquartered in San Diego, United States.
When was Pyxis Diagnostics founded?
Pyxis Diagnostics was founded in 2017.
What industry does Pyxis Diagnostics operate in?
Pyxis Diagnostics operates in Healthcare, Immunotherapy, Oncology, Next Generation Sequencing, Proteomics.
How many employees does Pyxis Diagnostics have?
Pyxis Diagnostics has approximately 3 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.